Maple Capital Management Inc. raised its position in Colgate-Palmolive Company (NYSE:CL – Free Report) by 11.9% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 141,870 shares of the company’s stock after purchasing an additional 15,138 shares during the period. Maple Capital Management Inc.’s holdings in Colgate-Palmolive were worth $13,293,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CL. Brighton Jones LLC lifted its holdings in Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after purchasing an additional 450 shares in the last quarter. Bernard Wealth Management Corp. purchased a new position in Colgate-Palmolive in the 4th quarter valued at $36,000. NorthRock Partners LLC lifted its holdings in Colgate-Palmolive by 105.3% in the 4th quarter. NorthRock Partners LLC now owns 8,409 shares of the company’s stock valued at $764,000 after purchasing an additional 4,314 shares in the last quarter. Man Group plc lifted its holdings in Colgate-Palmolive by 6.0% in the 4th quarter. Man Group plc now owns 532,849 shares of the company’s stock valued at $48,441,000 after purchasing an additional 29,994 shares in the last quarter. Finally, Mufg Securities Americas Inc. purchased a new position in Colgate-Palmolive in the 4th quarter valued at $1,096,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Analysts Set New Price Targets
Several research analysts have recently commented on CL shares. JPMorgan Chase & Co. reduced their price target on Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Morgan Stanley reduced their price target on Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Barclays lifted their price target on Colgate-Palmolive from $86.00 to $87.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 15th. Wells Fargo & Company reduced their price target on Colgate-Palmolive from $88.00 to $83.00 and set an “underweight” rating on the stock in a report on Monday, August 4th. Finally, UBS Group reduced their price target on Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating on the stock in a report on Thursday, July 17th. Seven research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average price target of $98.00.
Colgate-Palmolive Stock Up 1.0%
Shares of CL opened at $84.06 on Friday. The firm has a market cap of $67.94 billion, a P/E ratio of 23.61, a price-to-earnings-growth ratio of 4.33 and a beta of 0.35. Colgate-Palmolive Company has a 12-month low of $82.29 and a 12-month high of $106.44. The company’s 50-day moving average price is $86.11 and its 200 day moving average price is $89.61. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.03. The firm had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. Colgate-Palmolive’s revenue was up 1.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.91 EPS. On average, sell-side analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.
Colgate-Palmolive Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be issued a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.5%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s payout ratio is 58.43%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- What is the FTSE 100 index?
- High-Flyers Near Resistance: 3 Stocks to Watch for a Dip
- How to Use the MarketBeat Excel Dividend Calculator
- Seagate Technology Leads S&P 500: What’s Behind Its 120% Gain?
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.